The RHOV gene is overexpressed in human non-small cell lung cancer

Cancer Genetics

Volumn 206, Issue 11, 2013, Pages 393-397

  Shepelev, Mikhail V ^a   Korobko, Igor V ^a  

^a INSTITUTE OF GENE BIOLOGY   (Russian Federation)

Author keywords

Non small cell lung cancer; Rho GTPases; RHOV; Squamous cell carcinoma

Indexed keywords

ARTICLE; CANCER CELL; CANCER DIAGNOSIS; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MARKER GENE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RHOV GENE; UPREGULATION;

RATTUS;

NON-SMALL-CELL LUNG CANCER; RHO GTPASES; RHOV; SQUAMOUS CELL CARCINOMA;

CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GTP-BINDING PROTEINS; HUMANS; LUNG NEOPLASMS; NEOPLASM PROTEINS; PROGNOSIS;

EID: 84892981140     PISSN: 22107762     EISSN: 22107770     Source Type: Journal    
DOI: 10.1016/j.cancergen.2013.10.006     Document Type: Article

References (32)

1. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013, 63:11-30.
2. Devesa S.S., Bray F., Vizcaino A.P., et al. International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising. Int J Cancer 2005, 117:294-299.
3. Karlsson R., Pedersen E.D., Wang Z., et al. Rho GTPase function in tumorigenesis. Biochim Biophys Acta 2009, 1796:91-98.
4. Aronheim A., Broder Y.C., Cohen A., et al. Chp, a homologue of the GTPase Cdc42Hs, activates the JNK pathway and is implicated in reorganizing the actin cytoskeleton. Curr Biol 1998, 8:1125-1128.
5. Katoh M. Molecular cloning and characterization of WRCH2 on human chromosome 15q15. Int J Oncol 2002, 20:977-982.
6. Chenette E.J., Abo A., Der C.J. Critical and distinct roles of amino- and carboxyl-terminal sequences in regulation of the biological activity of the Chp atypical Rho GTPase. J Biol Chem 2005, 280:13784-13792.
7. Chenette E.J., Mitin N.Y., Der C.J. Multiple sequence elements facilitate Chp Rho GTPase subcellular location, membrane association, and transforming activity. Mol Biol Cell 2006, 17:3108-3121.
8. Aspenstrom P., Fransson A., Saras J. Rho GTPases have diverse effects on the organization of the actin filament system. Biochem J 2004, 377:327-337.
9. Weisz Hubsman M., Volinsky N., Manser E., et al. Autophosphorylation-dependent degradation of Pak1, triggered by the Rho-family GTPase, Chp. Biochem J 2007, 404:487-497.
10. Dummler B., Ohshiro K., Kumar R., et al. Pak protein kinases and their role in cancer. Cancer Metastasis Rev 2009, 28:51-63.
11. Shepelev M.V., Chernoff J., Korobko I.V. Rho family GTPase Chp/RhoV induces PC12 apoptotic cell death via JNK activation. Small GTPases 2011, 2:17-26.
12. Bhavsar P.J., Infante E., Khwaja A., et al. Analysis of Rho GTPase expression in T-ALL identifies RhoU as a target for Notch involved in T-ALL cell migration. Oncogene 2013, 32:198-208.
13. Kalinichenko S.V., Kopantzev E.P., Korobko E.V., et al. Pdcd4 protein and mRNA level alterations do not correlate in human lung tumors. Lung Cancer 2008, 62:173-180.
14. Liu D.W., Chen S.T., Liu H.P. Choice of endogenous control for gene expression in nonsmall cell lung cancer. Eur Respir J 2005, 26:1002-1008.
15. Bustin S.A., Benes V., Garson J.A., et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 2009, 55:611-622.
16. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
17. Hou J., Aerts J., den Hamer B., et al. Gene expression-based classification of non-small cell lung carcinomas and survival prediction. PLoS One 2010, 5:e10312.
18. Kaiser S., Park Y.K., Franklin J.L., et al. Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer. Genome Biol 2007, 8:R131.
19. Radvanyi L., Singh-Sandhu D., Gallichan S., et al. The gene associated with trichorhinophalangeal syndrome in humans is overexpressed in breast cancer. Proc Natl Acad Sci USA 2005, 102:11005-11010.
20. Liu Y., Wang Y., Zhang Y., et al. Abnormal expression of p120-catenin, E-cadherin, and small GTPases is significantly associated with malignant phenotype of human lung cancer. Lung Cancer 2009, 63:375-382.
21. Yuan K., Qian C., Zheng R. Prognostic significance of immunohistochemical Rac1 expression in survival in early operable non-small cell lung cancer. Med Sci Monit 2009, 15:BR313-BR319.
22. Zhang C., Zhou F., Li N., et al. Overexpression of RhoE has a prognostic value in non-small cell lung cancer. Ann Surg Oncol 2007, 14:2628-2635.
23. Shikada Y., Yoshino I., Okamoto T., et al. Higher expression of RhoC is related to invasiveness in non-small cell lung carcinoma. Clin Cancer Res 2003, 9:5282-5286.
24. Mazieres J., Tovar D., He B., et al. Epigenetic regulation of RhoB loss of expression in lung cancer. BMC Cancer 2007, 7:220.
25. Sato N., Fukui T., Taniguchi T., et al. RhoB is frequently downregulated in non-small-cell lung cancer and resides in the 2p24 homozygous deletion region of a lung cancer cell line. Int J Cancer 2007, 120:543-551.
26. Krauthammer M., Kong Y., Ha B.H., et al. Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nat Genet 2012, 44:1006-1014.
27. Kawazu M., Ueno T., Kontani K., et al. Transforming mutations of RAC guanosine triphosphatases in human cancers. Proc Natl Acad Sci USA 2013, 110:3029-3034.
28. Liu J., Lee W., Jiang Z., et al. Genome and transcriptome sequencing of lung cancers reveal diverse mutational and splicing events. Genome Res 2012, 22:2315-2327.
29. Shutes A., Berzat A.C., Chenette E.J., et al. Biochemical analyses of the Wrch atypical Rho family GTPases. Methods Enzymol 2006, 406:11-26.
30. Guemar L., de Santa Barbara P., Vignal E., et al. The small GTPase RhoV is an essential regulator of neural crest induction in Xenopus. Dev Biol 2007, 310:113-128.
31. Faure S., Fort P. Atypical RhoV and RhoU GTPases control development of the neural crest. Small Gtpases 2011, 2:310-313.
32. Shapiro M., Akiri G., Chin C., et al. Wnt pathway activation predicts increased risk of tumor recurrence in patients with stage I nonsmall cell lung cancer. Ann Surg 2013, 257:548-554.